Healthcare provider profile · identity verified

Edward Garofolo

Family Practice · MURRYSVILLE, PA · NPI 1932176781

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	198	54
Metoprolol Succinate	Metoprolol Succinate	159	46
Pantoprazole Sodium	Pantoprazole Sodium	159	42
Simvastatin	Simvastatin	152	43
Lisinopril	Lisinopril	149	49
Atorvastatin Calcium	Atorvastatin Calcium	145	45
Famotidine	Famotidine	139	36
Lorazepam	Lorazepam	132	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	127	22
Omeprazole	Omeprazole	119	39
Rosuvastatin Calcium	Rosuvastatin Calcium	118	43
Amlodipine Besylate	Amlodipine Besylate	117	36
Tamsulosin Hcl	Tamsulosin Hcl	114	26
Prednisone	Prednisone	112	85
Gabapentin	Gabapentin	111	31
Doxycycline Hyclate	Doxycycline Hyclate	109	81
Duloxetine Hcl	Duloxetine Hcl	93	24
Alprazolam	Alprazolam	91	22
Losartan Potassium	Losartan Potassium	91	27
Metoprolol Tartrate	Metoprolol Tartrate	91	28
Albuterol Sulfate Hfa	Albuterol Sulfate	82	32
Bupropion Xl	Bupropion Hcl	81	13
Fluticasone Propionate	Fluticasone Propionate	79	35
Hydrochlorothiazide	Hydrochlorothiazide	76	22
Furosemide	Furosemide	72	28
Trazodone Hcl	Trazodone Hcl	72	24
Zolpidem Tartrate	Zolpidem Tartrate	71	16
Citalopram Hbr	Citalopram Hydrobromide	70	18
Metformin Hcl	Metformin Hcl	70	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	69	61
Eliquis	Apixaban	69	14
Ondansetron Hcl	Ondansetron Hcl	69	15
Ezetimibe	Ezetimibe	68	21
Methylprednisolone	Methylprednisolone	60	51
Fluoxetine Hcl	Fluoxetine Hcl	56	15
Meloxicam	Meloxicam	52	22
Sertraline Hcl	Sertraline Hcl	51	17
Buspirone Hcl	Buspirone Hcl	50	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	11
Jardiance	Empagliflozin	45	14
Valsartan	Valsartan	45	14
Glimepiride	Glimepiride	42	11
Levofloxacin	Levofloxacin	42	34
Mirtazapine	Mirtazapine	42	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	25
Ibuprofen	Ibuprofen	41	17
Ozempic	Semaglutide	39	suppressed
Spiriva Respimat	Tiotropium Bromide	39	suppressed
Atenolol	Atenolol	38	13
Synthroid	Levothyroxine Sodium	38	12
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	13
Tramadol Hcl	Tramadol Hcl	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	26
Finasteride	Finasteride	33	suppressed
Potassium Chloride	Potassium Chloride	33	13
Jantoven	Warfarin Sodium	32	suppressed
Propranolol Hcl Er	Propranolol Hcl	32	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	31	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Spironolactone	Spironolactone	30	11
Escitalopram Oxalate	Escitalopram Oxalate	29	11
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	29	29
Allopurinol	Allopurinol	28	suppressed
Carvedilol	Carvedilol	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	25	14
Entresto	Sacubitril/Valsartan	23	suppressed
Azithromycin	Azithromycin	22	19
Triamcinolone Acetonide	Triamcinolone Acetonide	22	16
Cephalexin	Cephalexin	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Naproxen	Naproxen	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Fluconazole	Fluconazole	19	14
Meclizine Hcl	Meclizine Hcl	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Ibu	Ibuprofen	18	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Topiramate	Topiramate	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Linzess	Linaclotide	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Triazolam	Triazolam	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Oxazepam	Oxazepam	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Irbesartan	Irbesartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error